A recent survey highlighted a widespread lack of understanding about the much-publicised GLP-1 weight-loss medications ...

Weight loss jabs will not be enough to make “lasting progress” on tackling the obesity epidemic, leading medics have said.

Novo Nordisk is in the lead, but not alone. Obesity doctors say they are gearing up for demand, predicted to be high. Some ...

Weight loss injections will not be enough to make “lasting progress” in tackling the obesity epidemic, leading medical experts have warned.

The researchers found health perks directly linked with weight loss through blood test results, including increases in HDL ...

Research shows morning workouts may be optimal for weight loss and mental health, though experts stress that quality sleep ...

Researchers say GLP-1 medicines might be able to help with migraines.

Study finds the GLP-1 drug liraglutide reduced migraine days by almost 50% in patients with obesity, with quality of life ...

Data from 32 studies concluded that the impact of exercise is modest in terms of meaningful weight loss. Caloric restriction ...

Business Insider spoke to Eli Lilly's new president of cardiometabolic health, who shared the company's aggressive incretin ...

Insurers are cutting coverage, citing costs. But there’s seldom any discussion of the return on investment from these drugs ...